Empagliflozin in heart failure with a preserved ejection fraction SD Anker, J Butler, G Filippatos, JP Ferreira, E Bocchi, M Böhm, ... New England Journal of Medicine 385 (16), 1451-1461, 2021 | 2977 | 2021 |
Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology … B Bozkurt, AJS Coats, H Tsutsui, M Abdelhamid, S Adamopoulos, N Albert, ... Journal of cardiac failure 27 (4), 387-413, 2021 | 1574 | 2021 |
Thrombosis and Coagulopathy in COVID-19 JE Gomez-Mesa, S Galindo-Coral, MC Montes, AJM Martin Current problems in cardiology 46 (3), 100742, 2021 | 313 | 2021 |
Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved … SD Anker, J Butler, GS Filippatos, W Jamal, A Salsali, J Schnee, K Kimura, ... European journal of heart failure 21 (10), 1279-1287, 2019 | 230 | 2019 |
The patient perspective: quality of life in advanced heart failure with frequent hospitalisations MS Nieminen, K Dickstein, C Fonseca, JM Serrano, J Parissis, F Fedele, ... International journal of cardiology 191, 256-264, 2015 | 198 | 2015 |
World heart federation roadmap for heart failure. JP Ferreira, S Kraus, S Mitchell, P Perel, D Piñeiro, O Chioncel, R Colque, ... Global heart 14 (3), 197-214, 2019 | 114 | 2019 |
Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR‐Preserved trial SD Anker, J Butler, G Filippatos, M Shahzeb Khan, JP Ferreira, E Bocchi, ... European journal of heart failure 22 (12), 2383-2392, 2020 | 101 | 2020 |
EMPEROR-Preserved Trial Committees and Investigators. Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial SD Anker, J Butler, G Filippatos, M Shahzeb Khan, JP Ferreira, E Bocchi, ... Eur J Heart Fail 22 (12), 2383-2392, 2020 | 61 | 2020 |
A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry P Joseph, H Dokainish, T McCready, A Budaj, A Roy, G Ertl, ... American Heart Journal 227, 56-63, 2020 | 37 | 2020 |
Global variations in heart failure etiology, management, and outcomes P Joseph, A Roy, E Lonn, S Störk, J Floras, L Mielniczuk, JL Rouleau, ... Jama 329 (19), 1650, 2023 | 31 | 2023 |
Diseccion aórtica: estado actual E Contreras Zúñiga, SX Zuluaga Martínez, JE Gómez Mesa, ... Revista costarricense de cardiología 11 (1), 19-27, 2009 | 27 | 2009 |
Consenso colombiano de falla cardíaca avanzada: capítulo de Falla Cardíaca, Trasplante Cardíaco e Hipertensión Pulmonar de la Sociedad Colombiana de Cardiología y Cirugía … JE Gómez-Mesa, C Saldarriaga, AM Jurado, A Mariño, A Rivera, ... Revista Colombiana de Cardiología 26, 3-24, 2019 | 26 | 2019 |
Cardiovascular risk factors and clinical outcomes among patients hospitalized with COVID-19: findings from the world heart Federation COVID-19 study D Prabhakaran, K Singh, D Kondal, L Raspail, B Mohan, T Kato, ... Global heart 17 (1), 2022 | 22 | 2022 |
Registro colombiano de falla cardiaca (RECOLFACA): resultados JE Gómez-Mesa, CI Saldarriaga-Giraldo, LE Echeverría-Correa, ... Revista Colombiana de Cardiología 28 (4), 334-344, 2021 | 12 | 2021 |
Colombian heart failure registry (RECOLFACA): methodology and preliminary data JE Gómez-Mesa, CI Saldarriaga, LE Echeverría, P Luna Revista Colombiana de Cardiología 28 (3), 217-230, 2021 | 12 | 2021 |
Registro colombiano de falla cardiaca (RECOLFACA): metodología y datos preliminares JE Gómez-Mesa, CI Saldarriaga, LE Echeverría, P Luna Revista Colombiana de Cardiología 28 (3), 217-230, 2021 | 10 | 2021 |
Endovascular and medical therapy of may–thurner syndrome: case series and scoping literature review MC Montes, JP Carbonell, JE Gómez-Mesa JMV-Journal de Médecine Vasculaire 46 (2), 80-89, 2021 | 9 | 2021 |
Global variations in heart failure etiology, management, and outcomes G-CHF Investigators JAMA-Journal of the American Medical Association 329 (19), 1650-1661, 2023 | 8* | 2023 |
Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved SD Anker, J Butler, MS Usman, G Filippatos, JP Ferreira, E Bocchi, ... Nature medicine 28 (12), 2512-2520, 2022 | 8 | 2022 |
Latin-American registry of cardiovascular disease and COVID-19: rationale and design of the CARDIO COVID 19-20 registry JE Gómez-Mesa, S Galindo-Coral, MC Montes, W Alarco, JL Barisani, ... Global Heart 16 (1), 2021 | 8 | 2021 |